Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)

DTVP Veroffentlichung Germany has Released a tender for Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form) in Pharmaceuticals. The tender was released on May 22, 2024.

Country - Germany

Summary - Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)

Deadline - Apr 30, 2026

MT reference number - 82029086

Product classification - Medicinal products for the alimentary tract and metabolism

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 82029086

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form)local title:: Arzneimittel mit dem Wirkstoff Rivaroxaban (ATC: B01AF01 - in der Wirkstärke 2,5 mg je abgeteilte orale Darreichungsform)type_of_procedure: Otherbidding_response_method: Not Available

Mt Ref Id - 82029086

Deadline - Apr 30, 2026

Share

Similar Tenders :